Nadine Molitor, Daniel Hofer, Tolga Çimen, Alessio Gasperetti, Deniz Akdis, Sarah Costa, Rolf Jenni, Alexander Breitenstein, Thomas Wolber, Stephan Winnik, Siv Fokstuen, Guan Fu, Argelia Medeiros-Domingo, Frank Ruschitzka, Corinna Brunckhorst, Firat Duru, Ardan M Saguner
INTRODUCTION: Implantable cardioverter-defibrillators (ICDs) can prevent sudden cardiac death due to ventricular arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC). The aim of our study was to assess the cumulative burden, evolution and potential triggers of appropriate ICD shocks during long-term follow-up, which may help to reduce and further refine individual arrhythmic risk in this challenging disease. METHODS: This retrospective cohort study included 53 patients with definite ARVC according to the 2010 Task Force Criteria from the multicentre Swiss ARVC Registry with an implanted ICD for primary or secondary prevention...
March 8, 2023: Heart